Investing.com — In a recent note to clients, RBC Capital Markets has outlined the top 10 questions investors are posing about the biotechnology sector, providing insights into the key issues driving market sentiment. 1) Among the most prominent inquiries is how the new Trump-led administration could impact the FDA. Investors are particularly curious about the role RFK Jr. might play if he were to hold a position in federal healthcare